Tekrarlayan Ameloblastoma: Olgu Sunumu

Ameloblastoma, çene bölgesinde görülen bir benign tümördür. En sık 20-50 yaş aralığında izlenir. Mandibulayı maksilladan daha sık tutar ve %80 oranında mandibular molar bölge ve ramus bölgesinde ortaya çıkar. Ameloblastoma yavaş büyür, ayrıca kemikte ekspansiyon ve destrüksiyon yapma eğilimindedir. Güncel sınıflamada ameloblastoma geleneksel, unikistik, ekstraosseöz/periferal ve metastaz yapan olmak üzere dört gruba ayrılmıştır. Ameloblastomalar kapsülsüz tümörlerdir ve bu sebeple çevre dokuya infiltre olurlar. Bu durum ise tümörün rekürrens riskini artırmaktadır. Bu nedenle büyük ameloblastoma olgularında mutlaka marjinal rezeksiyon yapılması gerekmektedir. Bu olguda 67 yaşında erkek hastanın, 33 yıl önce başka bir merkezde opere edilen ve şimdi tekrarlayarak büyük boyutlara ulaşmış olan mandibular ameloblastoma vakasının klinik ve radyolojik özelliklerinin sunulması amaçlanmıştır.

Recurrent Ameloblastoma: Case Report

Ameloblastoma is a benign tumor that occurs in the jaw area. It is most commonly seen in the 20-50 age range. It involves the mandible more often than the maxilla and occurs in 80% of the mandibular molar region and ramus region. Ameloblastoma grows slowly and also tends to expand and destroy bone. In the current classification, ameloblastoma is divided into four groups as traditional, unicystic, extraosseous / peripheral and metastasizing. Ameloblastomas are nonencapsulated tumors and therefore infiltrate the surrounding tissue. This situation increases the risk of tumor recurrence. Therefore, marginal resection must be performed in large ameloblastoma cases. In this case, it is aimed to present the clinical and radiological features of a 67-year-old male patient, who had been operated in another center 33 years ago and has now recurred to large dimensions.

___

  • 1. Angadi P. Head and Neck: Odontogenic tumor: Ameloblastoma. 2011.
  • 2. Belli E, Rendine G, Mazzone N. Ameloblastoma relapse after 50 years from resection treatment. J Craniofac Surg. 2009; 20(4): 1146-9.
  • 3. Masthan KMK, Anitha N, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015; 7(5): 167.
  • 4. Henderson JM, Sonnet JR, Schlesinger C, Ord RA. Pulmonary metastasis of ameloblastoma: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(2): 170-6.
  • 5. White S, Pharoah M. Oral Radiology: Principles and Interpretation. 7th Edition. 2014.
  • 6. Ramesh RS, Manjunath S, Ustad TH, Pais S, Shivakumar K. Unicystic ameloblastoma of the mandible - an unusual case report and review of literature. Head Neck Oncol. 2010; 14(2): 1.
  • 7. Sato K, Sudo S, Fukuya Y, Sakuma H. Maxillary ameloblastoma with intracranial invasion--case report. Neurol Med Chir (Tokyo). 1994; 34(10): 704- 7.
  • 8. Soluk-Tekkesin M, Wright JM. The world health organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) edition. Turk Patoloji Derg, 2018; 34(1): 1-18.
  • 9. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017; 11(1): 68-77.
  • 10. Shi HA, Ng CWB, Kwa CT, Sim QXC. Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies. The Surgeon 2020.
  • 11. Gerzenshtein J, Zhang F, Caplan J, Anand V, Lineaweaver W. Immediate mandibular reconstruction with microsurgical fibula flap transfer following wide resection for ameloblastoma. J Craniofac Surg. 2006; 17(1): 178-82.
  • 12. Çöloğlu A. Oral Patoloji “Ağız Patolojisi.” Yeditepe Üniversitesi Yayını; 2007.
  • 13. Almeida R de AC, Andrade ES de S, Barbalho JC, Vajgel A, Vasconcelos BC do E. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and metaanalysis. Int J Oral Maxillofac Surg. 2016; 45(3): 359-67.
  • 14. McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol. 2016; 273(7): 1649-61.
  • 15. EI-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumors. 4th ed. International Agency for Research on Cancer; 2017.
  • 16. Takahashi K, Miyauchi K, Sato K. Treatment of ameloblastoma in children. Br J Oral Maxillofac Surg. 1998; 36(6): 453-6.
  • 17. Gardner DG. A pathologist’s approach to the treatment of ameloblastoma. J Oral Maxillofac Surg. 1984; 42(3): 161-6.
  • 18. Vayvada H, Mola F, Menderes A, Yilmaz M. Surgical Management of Ameloblastoma in the Mandible: Segmental Mandibulectomy and Immediate Reconstruction With Free Fibula or Deep Circumflex Iliac Artery Flap (Evaluation of the Long-Term Esthetic and Functional Results). J Oral Maxillofac Surg. 2006; 64(10): 1532-9.
  • 19. Chaine A, Pitak-Arnnop P, Dhanuthai K, RuhinPoncet B, Bertrand J-Ch, Bertolus C. A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital. Eur J Surg Oncol EJSO. 2009; 35(9): 999-1005.
  • 20. Au SW, Li KY, Choi WS, Su YX. Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg. 2019; 48(10): 1300-6.
  • 21. Chai KS, Omar FH, Mat Saad AZ, Wan Sulaiman WA, Halim AS. A 20-year experience of immediate mandibular reconstruction using free fibula osteocutaneous flaps following ameloblastoma resection: Radical resection, outcomes, and recurrence. Arch Plast Surg. 2019; 46(5): 426-32.
  • 22. Hong J, Yun P-Y, Chung I-H, Myoung H, Suh J-D, Seo B-M, Lee J-H, Choung P-H. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 2007; 36(4): 283-8.
  • 23. Montoro JR de MC, Tavares MG, Melo DH, Franco R de L, Mello-Filho FV de, Xavier SP, Trivellato AE, Lucas AS. Mandibular ameloblastoma treated by bone resection and immediate reconstruction. Braz J Otorhinolaryngol. 2008; 74(1): 155-7.
  • 24. Adeel M, Rajput MSA, Arain AA, Baloch M, Khan M. Ameloblastoma: Management and Outcome. Cureus. 2018; 10(10): e3437.
  • 25. Pogrel MA, Montes DM. Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg. 2009; 38(8): 807-12.
  • 26. Olaitan AA, Adeola DS, Adekeye EO. Ameloblastoma: clinical features and management of 315 cases from Kaduna, Nigeria. J Cranio-Maxillofac Surg Off Publ Eur Assoc Cranio-Maxillo-fac Surg. 1993; 21(8): 351-5.
  • 27. Pandya NJ, Stuteville OH. Treatment of ameloblastoma. Plast Reconstr Surg. 1972; 50(3): 242-8.
Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi-Cover
  • Yayın Aralığı: Yılda 3 Sayı
  • Yayıncı: DÜZCE ÜNİVERSİTESİ